An Adaptive Study to Match Patients With Solid Tumors to Various Immunotherapy Combinations Based Upon a Broad Biomarker Assessment
Clinical trial NCT03335540 · COMPLETED
Trial details
- NCT number
- NCT03335540
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-07
- Primary completion
- 2021-03-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.